Filing Details
- Accession Number:
- 0001437749-24-006519
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-04 21:38:18
- Reporting Period:
- 2024-02-29
- Accepted Time:
- 2024-03-04 21:38:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1158895 | Lemaitre Vascular Inc | LMAT | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1365733 | Jr P Joseph Pellegrino | C/O Lemaitre Vascular, Inc. 63 Second Avenue Burlington MA 01803 | Chief Financial Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-29 | 3,461 | $31.30 | 12,996 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-02-29 | 8,733 | $23.56 | 21,729 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-02-29 | 5,883 | $35.48 | 27,612 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-02-29 | 5,346 | $37.29 | 32,958 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-02-29 | 7,031 | $48.60 | 39,989 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-02-29 | 3,430 | $47.19 | 43,419 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-29 | 1,979 | $68.56 | 41,440 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-29 | 28,461 | $69.72 | 12,979 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-29 | 6,250 | $70.27 | 6,729 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-29 | 277 | $71.19 | 6,452 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-29 | 2 | $0.00 | 6,450 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-02-29 | 2,649 | $0.00 | 9,099 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2024-02-29 | 6 | $0.00 | 9,105 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-29 | 296 | $70.00 | 8,809 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-02-29 | 3,461 | $0.00 | 3,461 | $31.30 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-02-29 | 8,733 | $0.00 | 8,733 | $23.56 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-02-29 | 5,883 | $0.00 | 5,883 | $35.48 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-02-29 | 5,346 | $0.00 | 5,346 | $37.29 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-02-29 | 7,031 | $0.00 | 7,031 | $48.60 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-02-29 | 3,430 | $0.00 | 3,430 | $47.19 |
| Common Stock | Dividend Equivalent Rights | Disposition | 2024-02-29 | 7 | $0.00 | 7 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-12-22 | 2024-12-22 | No | 4 | M | Direct |
| 0 | 2018-12-19 | 2025-12-19 | No | 4 | M | Direct |
| 2,941 | 2019-12-20 | 2026-12-20 | No | 4 | M | Direct |
| 5,345 | 2020-12-02 | 2027-12-02 | No | 4 | M | Direct |
| 7,030 | 2021-12-11 | 2028-12-11 | No | 4 | M | Direct |
| 10,291 | 2022-12-12 | 2029-12-12 | No | 4 | M | Direct |
| 20 | No | 4 | M | Direct |
Footnotes
- Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
- The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $68.05 to $69.04. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
- The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $69.05 to $70.045. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
- The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $70.05 to $70.62. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
- Represents shares from the release of fractional dividend equivalent rights returned to company.
- These shares represent LMAT common stock acquired on February 29, 2024, upon settlement of a Performance Share Unit (PSU) award granted on December 12, 2022. The PSU award vests as follows: 25% upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next three years.
- Each PSU represents a contingent right to receive one share of common stock upon vesting based on the attainment of performance goals.
- Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
- These shares represent shares withheld by the issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on December 12, 2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
- This option is fully vested and exercisable.
- This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.
- These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Billionaire Hedge Funds
